Multiple sclerosis

Treatment Phase: Initial treatment

Clinical criteria:

  • The condition must be diagnosed as clinically definite relapsing-remitting multiple sclerosis by magnetic resonance imaging of the brain and/or spinal cord; OR

  • The condition must be diagnosed as clinically definite relapsing-remitting multiple sclerosis, with written certification provided by a radiologist that a magnetic resonance imaging scan is contraindicated because of the risk of physical (not psychological) injury to the patient,

AND

  • Patient must have experienced at least 2 documented attacks of neurological dysfunction, believed to be due to multiple sclerosis, in the preceding 2 years of commencing a PBS-subsidised disease modifying therapy for this condition,

AND

  • Patient must be ambulatory (without assistance or support).

Treatment criteria:

  • Must be treated by a medical practitioner; OR

  • Must be treated by a nurse practitioner in consultation with a specialist physician.

Where applicable, the date of the magnetic resonance imaging scan must be recorded in the patient's medical records.

Note

No increase in the maximum quantity or number of units may be authorised.

Note

No increase in the maximum number of repeats may be authorised.

Multiple sclerosis

Treatment Phase: Continuing treatment

Clinical criteria:

  • The condition must be diagnosed as clinically definite relapsing-remitting multiple sclerosis,

AND

  • Patient must have previously received PBS-subsidised treatment with this drug for this condition,

AND

  • Patient must not show continuing progression of disability while on treatment with this drug,

AND

  • Patient must have demonstrated compliance with, and an ability to tolerate this therapy.

Treatment criteria:

  • Must be treated by a medical practitioner; OR

  • Must be treated by a nurse practitioner in consultation with a specialist physician.

Note

No increase in the maximum quantity or number of units may be authorised.

Note

No increase in the maximum number of repeats may be authorised.